Silodosin

سیلودوزین

⚠ Unverified

🚻 Genito Urinary System And Sex HormonesAlpha-1A blocker

Market / country: 🇺🇸 USA

Rapaflo (US)

🧮 Dose calculator

Benign prostatic hyperplasia (BPH) · Regimen source: FDA Silodosin · 2.1

Enter age (weight is optional for this regimen).

🛡️ Safety & information

Contraindications

  • ⛔ Severe renal impairment (CrCl <30); severe hepatic impairment (Child-Pugh ≥10); strong CYP3A4 inhibitors; hypersensitivity. FDA Silodosin · 4

Warnings

  • • Postural hypotension and syncope; exclude prostate cancer first; intraoperative floppy iris syndrome (IFIS) in cataract surgery. FDA Silodosin · 5

Renal adjustment

Formulations

👥 Special populations

  • 🤰 PregnancyUse with caution

    Label states no clear risk or has limited data; use only if needed, under medical advice. FDA Silodosin · 8.1

    “Risk Summary Silodosin is not indicated for use in females.”
  • 🤱 BreastfeedingUse with caution

    Label: use with caution while breastfeeding; see the label text. FDA Silodosin · 8.2

    “Silodosin is not indicated for use in females.”
  • 👶 ChildrenSafety not established

    Label: safety and effectiveness in children have not been established. FDA Silodosin · 8.4

    “Safety and effectiveness in pediatric patients have not been established.”
  • 👴 Older adultsUse with caution

    Label: use with caution in older adults, usually starting at the low end of the dose range. FDA Silodosin · 8.5

    “In double-blind, placebo-controlled, 12-week clinical studies of silodosin, 259 (55.6%) were under 65 years of age, 207 (44.4%) patients were 65 years of age and over, while 60 (12.9%) patients were 75 years of age and over.Orthostatic hypotension was reported in 2.3% of silodosin patients < 65 years of age (1.2% for …”
  • ⚥ Females & males of reproductive potentialUse with caution

    Label has advice on pregnancy testing, contraception or fertility for females and males. FDA Silodosin · 8.3

    “Infertility Males Possible effects on male fertility could be observed based on findings in rats at exposures that were at least two times higher than at the MRHD (based on AUC).”

📚 Reference status for this drug

Shows which sources have references recorded for this drug and which do not.

🔗 Similar drugs

Doz is only a support tool and does not replace clinical judgment or official sources. Check every dose against the original source before prescribing. About & disclaimer · Sources

Information on this site is compiled from online websites and references. Doz accepts no responsibility for self-medication without approval from a physician and a reliable reference, or for any consequences of using this information.

Inspired by the Saphira project; part of the content is taken from it.

For suggestions, corrections, adding drugs or anything else, you can contact me on Telegram: @cenaav